nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent ethyl—DGAT1—connective tissue—skin cancer	0.0383	0.226	CbGeAlD
Icosapent ethyl—DGAT1—skin of body—skin cancer	0.0346	0.204	CbGeAlD
Icosapent ethyl—DGAT1—mammalian vulva—skin cancer	0.0315	0.186	CbGeAlD
Icosapent ethyl—DGAT1—female reproductive system—skin cancer	0.027	0.159	CbGeAlD
Icosapent ethyl—DGAT1—head—skin cancer	0.0225	0.133	CbGeAlD
Icosapent ethyl—DGAT1—lymph node—skin cancer	0.0158	0.093	CbGeAlD
Icosapent ethyl—Dihomo-gamma-linolenic acid—PTGS2—skin cancer	0.00836	0.56	CrCbGaD
Icosapent ethyl—Icosapent—PTGS2—skin cancer	0.00656	0.44	CrCbGaD
Icosapent ethyl—Alopecia—Vemurafenib—skin cancer	0.00373	0.00457	CcSEcCtD
Icosapent ethyl—Malnutrition—Vemurafenib—skin cancer	0.00367	0.0045	CcSEcCtD
Icosapent ethyl—Rhinitis—Imiquimod—skin cancer	0.00361	0.00442	CcSEcCtD
Icosapent ethyl—Dysgeusia—Vemurafenib—skin cancer	0.0036	0.00441	CcSEcCtD
Icosapent ethyl—Pharyngitis—Imiquimod—skin cancer	0.00357	0.00438	CcSEcCtD
Icosapent ethyl—Back pain—Vemurafenib—skin cancer	0.00355	0.00436	CcSEcCtD
Icosapent ethyl—Myocardial ischaemia—Docetaxel—skin cancer	0.00355	0.00436	CcSEcCtD
Icosapent ethyl—Gastroenteritis—Temozolomide—skin cancer	0.00352	0.00431	CcSEcCtD
Icosapent ethyl—Asthenia—Vismodegib—skin cancer	0.00348	0.00427	CcSEcCtD
Icosapent ethyl—Pruritus—Vismodegib—skin cancer	0.00343	0.00421	CcSEcCtD
Icosapent ethyl—Chills—Imiquimod—skin cancer	0.00323	0.00396	CcSEcCtD
Icosapent ethyl—Arrhythmia—Imiquimod—skin cancer	0.00321	0.00394	CcSEcCtD
Icosapent ethyl—Cough—Vemurafenib—skin cancer	0.0032	0.00393	CcSEcCtD
Icosapent ethyl—Alopecia—Imiquimod—skin cancer	0.00318	0.0039	CcSEcCtD
Icosapent ethyl—Malnutrition—Imiquimod—skin cancer	0.00313	0.00384	CcSEcCtD
Icosapent ethyl—Arthralgia—Vemurafenib—skin cancer	0.00313	0.00383	CcSEcCtD
Icosapent ethyl—Myalgia—Vemurafenib—skin cancer	0.00313	0.00383	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Dactinomycin—skin cancer	0.0031	0.00381	CcSEcCtD
Icosapent ethyl—Vomiting—Vismodegib—skin cancer	0.00308	0.00378	CcSEcCtD
Icosapent ethyl—Affect lability—Temozolomide—skin cancer	0.00307	0.00376	CcSEcCtD
Icosapent ethyl—Rash—Vismodegib—skin cancer	0.00306	0.00375	CcSEcCtD
Icosapent ethyl—Dermatitis—Vismodegib—skin cancer	0.00306	0.00375	CcSEcCtD
Icosapent ethyl—Back pain—Imiquimod—skin cancer	0.00303	0.00372	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Vemurafenib—skin cancer	0.003	0.00368	CcSEcCtD
Icosapent ethyl—Dysphagia—Dactinomycin—skin cancer	0.00298	0.00365	CcSEcCtD
Icosapent ethyl—Infection—Vemurafenib—skin cancer	0.00298	0.00365	CcSEcCtD
Icosapent ethyl—Mood swings—Temozolomide—skin cancer	0.00295	0.00362	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Imiquimod—skin cancer	0.00291	0.00356	CcSEcCtD
Icosapent ethyl—Pneumonia—Bleomycin—skin cancer	0.00286	0.00351	CcSEcCtD
Icosapent ethyl—Malaise—Imiquimod—skin cancer	0.00282	0.00346	CcSEcCtD
Icosapent ethyl—Syncope—Imiquimod—skin cancer	0.00281	0.00344	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Bleomycin—skin cancer	0.00281	0.00344	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Temozolomide—skin cancer	0.00281	0.00344	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Bleomycin—skin cancer	0.00279	0.00342	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Imiquimod—skin cancer	0.00275	0.00338	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Temozolomide—skin cancer	0.00275	0.00337	CcSEcCtD
Icosapent ethyl—Colitis—Docetaxel—skin cancer	0.00274	0.00336	CcSEcCtD
Icosapent ethyl—Cough—Imiquimod—skin cancer	0.00273	0.00335	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00273	0.00335	CcSEcCtD
Icosapent ethyl—Cardiac arrest—Fluorouracil—skin cancer	0.00273	0.00335	CcSEcCtD
Icosapent ethyl—Abdominal distension—Temozolomide—skin cancer	0.00271	0.00333	CcSEcCtD
Icosapent ethyl—Fluid retention—Docetaxel—skin cancer	0.00271	0.00332	CcSEcCtD
Icosapent ethyl—Hypertension—Imiquimod—skin cancer	0.0027	0.00332	CcSEcCtD
Icosapent ethyl—Dysphagia—Temozolomide—skin cancer	0.00269	0.0033	CcSEcCtD
Icosapent ethyl—Pneumonia—Dactinomycin—skin cancer	0.00267	0.00328	CcSEcCtD
Icosapent ethyl—Chest pain—Imiquimod—skin cancer	0.00267	0.00327	CcSEcCtD
Icosapent ethyl—Myalgia—Imiquimod—skin cancer	0.00267	0.00327	CcSEcCtD
Icosapent ethyl—Arthralgia—Imiquimod—skin cancer	0.00267	0.00327	CcSEcCtD
Icosapent ethyl—Discomfort—Imiquimod—skin cancer	0.00263	0.00323	CcSEcCtD
Icosapent ethyl—Dry mouth—Imiquimod—skin cancer	0.00261	0.0032	CcSEcCtD
Icosapent ethyl—Decreased appetite—Vemurafenib—skin cancer	0.00261	0.0032	CcSEcCtD
Icosapent ethyl—Bronchitis—Temozolomide—skin cancer	0.00259	0.00318	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00259	0.00317	CcSEcCtD
Icosapent ethyl—Neoplasm—Docetaxel—skin cancer	0.00258	0.00317	CcSEcCtD
Icosapent ethyl—Constipation—Vemurafenib—skin cancer	0.00256	0.00314	CcSEcCtD
Icosapent ethyl—Oedema—Imiquimod—skin cancer	0.00256	0.00313	CcSEcCtD
Icosapent ethyl—Infection—Imiquimod—skin cancer	0.00254	0.00311	CcSEcCtD
Icosapent ethyl—Shock—Imiquimod—skin cancer	0.00251	0.00308	CcSEcCtD
Icosapent ethyl—Tachycardia—Imiquimod—skin cancer	0.00249	0.00306	CcSEcCtD
Icosapent ethyl—Dysphagia—Fluorouracil—skin cancer	0.00248	0.00304	CcSEcCtD
Icosapent ethyl—Erectile dysfunction—Temozolomide—skin cancer	0.00248	0.00304	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Imiquimod—skin cancer	0.00247	0.00303	CcSEcCtD
Icosapent ethyl—Anorexia—Imiquimod—skin cancer	0.00244	0.00299	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Temozolomide—skin cancer	0.00243	0.00298	CcSEcCtD
Icosapent ethyl—Angina pectoris—Fluorouracil—skin cancer	0.00242	0.00296	CcSEcCtD
Icosapent ethyl—Pneumonia—Temozolomide—skin cancer	0.00242	0.00296	CcSEcCtD
Icosapent ethyl—Infestation NOS—Temozolomide—skin cancer	0.0024	0.00295	CcSEcCtD
Icosapent ethyl—Infestation—Temozolomide—skin cancer	0.0024	0.00295	CcSEcCtD
Icosapent ethyl—Body temperature increased—Vemurafenib—skin cancer	0.00237	0.00291	CcSEcCtD
Icosapent ethyl—Pharyngitis—Dactinomycin—skin cancer	0.00237	0.0029	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00233	0.00286	CcSEcCtD
Icosapent ethyl—Insomnia—Imiquimod—skin cancer	0.00231	0.00284	CcSEcCtD
Icosapent ethyl—Chills—Bleomycin—skin cancer	0.00229	0.00281	CcSEcCtD
Icosapent ethyl—Dyspnoea—Imiquimod—skin cancer	0.00228	0.00279	CcSEcCtD
Icosapent ethyl—Alopecia—Bleomycin—skin cancer	0.00226	0.00277	CcSEcCtD
Icosapent ethyl—Sinusitis—Temozolomide—skin cancer	0.00225	0.00276	CcSEcCtD
Icosapent ethyl—Dyspepsia—Imiquimod—skin cancer	0.00225	0.00276	CcSEcCtD
Icosapent ethyl—Pneumonia—Fluorouracil—skin cancer	0.00223	0.00273	CcSEcCtD
Icosapent ethyl—Decreased appetite—Imiquimod—skin cancer	0.00222	0.00273	CcSEcCtD
Icosapent ethyl—Infestation NOS—Fluorouracil—skin cancer	0.00221	0.00271	CcSEcCtD
Icosapent ethyl—Infestation—Fluorouracil—skin cancer	0.00221	0.00271	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Imiquimod—skin cancer	0.00221	0.00271	CcSEcCtD
Icosapent ethyl—Pain—Imiquimod—skin cancer	0.00219	0.00268	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Fluorouracil—skin cancer	0.00218	0.00268	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Fluorouracil—skin cancer	0.00217	0.00266	CcSEcCtD
Icosapent ethyl—Asthenia—Vemurafenib—skin cancer	0.00215	0.00264	CcSEcCtD
Icosapent ethyl—Pharyngitis—Temozolomide—skin cancer	0.00214	0.00262	CcSEcCtD
Icosapent ethyl—Chills—Dactinomycin—skin cancer	0.00214	0.00262	CcSEcCtD
Icosapent ethyl—Pruritus—Vemurafenib—skin cancer	0.00212	0.0026	CcSEcCtD
Icosapent ethyl—Alopecia—Dactinomycin—skin cancer	0.00211	0.00258	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Imiquimod—skin cancer	0.00211	0.00258	CcSEcCtD
Icosapent ethyl—Epistaxis—Fluorouracil—skin cancer	0.00209	0.00256	CcSEcCtD
Icosapent ethyl—Sinusitis—Fluorouracil—skin cancer	0.00208	0.00255	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Bleomycin—skin cancer	0.00206	0.00253	CcSEcCtD
Icosapent ethyl—Migraine—Docetaxel—skin cancer	0.00204	0.0025	CcSEcCtD
Icosapent ethyl—Body temperature increased—Imiquimod—skin cancer	0.00202	0.00248	CcSEcCtD
Icosapent ethyl—Malaise—Bleomycin—skin cancer	0.00201	0.00246	CcSEcCtD
Icosapent ethyl—Rhinitis—Fluorouracil—skin cancer	0.00199	0.00244	CcSEcCtD
Icosapent ethyl—Dizziness—Vemurafenib—skin cancer	0.00198	0.00243	CcSEcCtD
Icosapent ethyl—Pharyngitis—Fluorouracil—skin cancer	0.00197	0.00242	CcSEcCtD
Icosapent ethyl—Cough—Bleomycin—skin cancer	0.00194	0.00238	CcSEcCtD
Icosapent ethyl—Chills—Temozolomide—skin cancer	0.00193	0.00237	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Dactinomycin—skin cancer	0.00193	0.00236	CcSEcCtD
Icosapent ethyl—Vomiting—Vemurafenib—skin cancer	0.00191	0.00234	CcSEcCtD
Icosapent ethyl—Alopecia—Temozolomide—skin cancer	0.00191	0.00234	CcSEcCtD
Icosapent ethyl—Chest pain—Bleomycin—skin cancer	0.00189	0.00232	CcSEcCtD
Icosapent ethyl—Myalgia—Bleomycin—skin cancer	0.00189	0.00232	CcSEcCtD
Icosapent ethyl—Rash—Vemurafenib—skin cancer	0.00189	0.00232	CcSEcCtD
Icosapent ethyl—Dermatitis—Vemurafenib—skin cancer	0.00189	0.00232	CcSEcCtD
Icosapent ethyl—Malnutrition—Temozolomide—skin cancer	0.00188	0.0023	CcSEcCtD
Icosapent ethyl—Discomfort—Bleomycin—skin cancer	0.00187	0.0023	CcSEcCtD
Icosapent ethyl—Malaise—Dactinomycin—skin cancer	0.00187	0.00229	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.00187	0.00229	CcSEcCtD
Icosapent ethyl—Dysgeusia—Temozolomide—skin cancer	0.00184	0.00225	CcSEcCtD
Icosapent ethyl—Asthenia—Imiquimod—skin cancer	0.00183	0.00225	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Docetaxel—skin cancer	0.00183	0.00224	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Bleomycin—skin cancer	0.00182	0.00223	CcSEcCtD
Icosapent ethyl—Oedema—Bleomycin—skin cancer	0.00182	0.00223	CcSEcCtD
Icosapent ethyl—Back pain—Temozolomide—skin cancer	0.00182	0.00223	CcSEcCtD
Icosapent ethyl—Pruritus—Imiquimod—skin cancer	0.00181	0.00222	CcSEcCtD
Icosapent ethyl—Infection—Bleomycin—skin cancer	0.0018	0.00221	CcSEcCtD
Icosapent ethyl—Dysphagia—Docetaxel—skin cancer	0.00179	0.0022	CcSEcCtD
Icosapent ethyl—Arrhythmia—Fluorouracil—skin cancer	0.00177	0.00218	CcSEcCtD
Icosapent ethyl—Myalgia—Dactinomycin—skin cancer	0.00177	0.00217	CcSEcCtD
Icosapent ethyl—Alopecia—Fluorouracil—skin cancer	0.00176	0.00215	CcSEcCtD
Icosapent ethyl—Discomfort—Dactinomycin—skin cancer	0.00175	0.00214	CcSEcCtD
Icosapent ethyl—Angina pectoris—Docetaxel—skin cancer	0.00174	0.00214	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Temozolomide—skin cancer	0.00174	0.00214	CcSEcCtD
Icosapent ethyl—Anorexia—Bleomycin—skin cancer	0.00173	0.00212	CcSEcCtD
Icosapent ethyl—Oedema—Dactinomycin—skin cancer	0.00169	0.00208	CcSEcCtD
Icosapent ethyl—Malaise—Temozolomide—skin cancer	0.00169	0.00208	CcSEcCtD
Icosapent ethyl—Dizziness—Imiquimod—skin cancer	0.00169	0.00207	CcSEcCtD
Icosapent ethyl—Vertigo—Temozolomide—skin cancer	0.00169	0.00207	CcSEcCtD
Icosapent ethyl—Infection—Dactinomycin—skin cancer	0.00168	0.00206	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00165	0.00203	CcSEcCtD
Icosapent ethyl—Cough—Temozolomide—skin cancer	0.00164	0.00201	CcSEcCtD
Icosapent ethyl—Vomiting—Imiquimod—skin cancer	0.00163	0.00199	CcSEcCtD
Icosapent ethyl—Hypertension—Temozolomide—skin cancer	0.00162	0.00199	CcSEcCtD
Icosapent ethyl—Dyspnoea—Bleomycin—skin cancer	0.00162	0.00199	CcSEcCtD
Icosapent ethyl—Anorexia—Dactinomycin—skin cancer	0.00161	0.00198	CcSEcCtD
Icosapent ethyl—Rash—Imiquimod—skin cancer	0.00161	0.00198	CcSEcCtD
Icosapent ethyl—Dermatitis—Imiquimod—skin cancer	0.00161	0.00197	CcSEcCtD
Icosapent ethyl—Pneumonia—Docetaxel—skin cancer	0.00161	0.00197	CcSEcCtD
Icosapent ethyl—Arthralgia—Temozolomide—skin cancer	0.0016	0.00196	CcSEcCtD
Icosapent ethyl—Myalgia—Temozolomide—skin cancer	0.0016	0.00196	CcSEcCtD
Icosapent ethyl—Infestation NOS—Docetaxel—skin cancer	0.0016	0.00196	CcSEcCtD
Icosapent ethyl—Infestation—Docetaxel—skin cancer	0.0016	0.00196	CcSEcCtD
Icosapent ethyl—Discomfort—Temozolomide—skin cancer	0.00158	0.00194	CcSEcCtD
Icosapent ethyl—Decreased appetite—Bleomycin—skin cancer	0.00158	0.00194	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Docetaxel—skin cancer	0.00157	0.00193	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Docetaxel—skin cancer	0.00157	0.00192	CcSEcCtD
Icosapent ethyl—Dry mouth—Temozolomide—skin cancer	0.00156	0.00192	CcSEcCtD
Icosapent ethyl—Pain—Bleomycin—skin cancer	0.00155	0.0019	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00154	0.00189	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Temozolomide—skin cancer	0.00153	0.00188	CcSEcCtD
Icosapent ethyl—Oedema—Temozolomide—skin cancer	0.00153	0.00188	CcSEcCtD
Icosapent ethyl—Infection—Temozolomide—skin cancer	0.00152	0.00187	CcSEcCtD
Icosapent ethyl—Epistaxis—Docetaxel—skin cancer	0.00151	0.00185	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Bleomycin—skin cancer	0.0015	0.00184	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Temozolomide—skin cancer	0.00148	0.00182	CcSEcCtD
Icosapent ethyl—Chest pain—Fluorouracil—skin cancer	0.00147	0.00181	CcSEcCtD
Icosapent ethyl—Myalgia—Fluorouracil—skin cancer	0.00147	0.00181	CcSEcCtD
Icosapent ethyl—Decreased appetite—Dactinomycin—skin cancer	0.00147	0.00181	CcSEcCtD
Icosapent ethyl—Anorexia—Temozolomide—skin cancer	0.00146	0.00179	CcSEcCtD
Icosapent ethyl—Discomfort—Fluorouracil—skin cancer	0.00145	0.00178	CcSEcCtD
Icosapent ethyl—Pain—Dactinomycin—skin cancer	0.00145	0.00178	CcSEcCtD
Icosapent ethyl—Rhinitis—Docetaxel—skin cancer	0.00144	0.00176	CcSEcCtD
Icosapent ethyl—Body temperature increased—Bleomycin—skin cancer	0.00144	0.00176	CcSEcCtD
Icosapent ethyl—Pharyngitis—Docetaxel—skin cancer	0.00142	0.00175	CcSEcCtD
Icosapent ethyl—Oedema—Fluorouracil—skin cancer	0.00141	0.00173	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Fluorouracil—skin cancer	0.00141	0.00173	CcSEcCtD
Icosapent ethyl—Infection—Fluorouracil—skin cancer	0.0014	0.00172	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Dactinomycin—skin cancer	0.0014	0.00171	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Temozolomide—skin cancer	0.0014	0.00171	CcSEcCtD
Icosapent ethyl—Insomnia—Temozolomide—skin cancer	0.00139	0.0017	CcSEcCtD
Icosapent ethyl—Tachycardia—Fluorouracil—skin cancer	0.00138	0.00169	CcSEcCtD
Icosapent ethyl—Dyspnoea—Temozolomide—skin cancer	0.00137	0.00167	CcSEcCtD
Icosapent ethyl—Dyspepsia—Temozolomide—skin cancer	0.00135	0.00165	CcSEcCtD
Icosapent ethyl—Anorexia—Fluorouracil—skin cancer	0.00135	0.00165	CcSEcCtD
Icosapent ethyl—Body temperature increased—Dactinomycin—skin cancer	0.00134	0.00164	CcSEcCtD
Icosapent ethyl—Decreased appetite—Temozolomide—skin cancer	0.00133	0.00163	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Temozolomide—skin cancer	0.00132	0.00162	CcSEcCtD
Icosapent ethyl—Pain—Temozolomide—skin cancer	0.00131	0.00161	CcSEcCtD
Icosapent ethyl—Constipation—Temozolomide—skin cancer	0.00131	0.00161	CcSEcCtD
Icosapent ethyl—Asthenia—Bleomycin—skin cancer	0.0013	0.0016	CcSEcCtD
Icosapent ethyl—Chills—Docetaxel—skin cancer	0.00129	0.00158	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00129	0.00158	CcSEcCtD
Icosapent ethyl—Pruritus—Bleomycin—skin cancer	0.00128	0.00158	CcSEcCtD
Icosapent ethyl—Arrhythmia—Docetaxel—skin cancer	0.00128	0.00157	CcSEcCtD
Icosapent ethyl—Insomnia—Fluorouracil—skin cancer	0.00128	0.00157	CcSEcCtD
Icosapent ethyl—Alopecia—Docetaxel—skin cancer	0.00127	0.00155	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Temozolomide—skin cancer	0.00126	0.00155	CcSEcCtD
Icosapent ethyl—Dyspnoea—Fluorouracil—skin cancer	0.00126	0.00154	CcSEcCtD
Icosapent ethyl—Malnutrition—Docetaxel—skin cancer	0.00125	0.00153	CcSEcCtD
Icosapent ethyl—Dyspepsia—Fluorouracil—skin cancer	0.00124	0.00152	CcSEcCtD
Icosapent ethyl—Decreased appetite—Fluorouracil—skin cancer	0.00123	0.0015	CcSEcCtD
Icosapent ethyl—Dysgeusia—Docetaxel—skin cancer	0.00122	0.0015	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00122	0.00149	CcSEcCtD
Icosapent ethyl—Asthenia—Dactinomycin—skin cancer	0.00122	0.00149	CcSEcCtD
Icosapent ethyl—Body temperature increased—Temozolomide—skin cancer	0.00121	0.00149	CcSEcCtD
Icosapent ethyl—Back pain—Docetaxel—skin cancer	0.00121	0.00148	CcSEcCtD
Icosapent ethyl—Pain—Fluorouracil—skin cancer	0.00121	0.00148	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Fluorouracil—skin cancer	0.00116	0.00143	CcSEcCtD
Icosapent ethyl—Vomiting—Bleomycin—skin cancer	0.00115	0.00142	CcSEcCtD
Icosapent ethyl—Rash—Bleomycin—skin cancer	0.00114	0.0014	CcSEcCtD
Icosapent ethyl—Dermatitis—Bleomycin—skin cancer	0.00114	0.0014	CcSEcCtD
Icosapent ethyl—Syncope—Docetaxel—skin cancer	0.00112	0.00137	CcSEcCtD
Icosapent ethyl—Body temperature increased—Fluorouracil—skin cancer	0.00112	0.00137	CcSEcCtD
Icosapent ethyl—Asthenia—Temozolomide—skin cancer	0.0011	0.00135	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Docetaxel—skin cancer	0.0011	0.00135	CcSEcCtD
Icosapent ethyl—Cough—Docetaxel—skin cancer	0.00109	0.00134	CcSEcCtD
Icosapent ethyl—Pruritus—Temozolomide—skin cancer	0.00108	0.00133	CcSEcCtD
Icosapent ethyl—Hypertension—Docetaxel—skin cancer	0.00108	0.00132	CcSEcCtD
Icosapent ethyl—Vomiting—Dactinomycin—skin cancer	0.00108	0.00132	CcSEcCtD
Icosapent ethyl—Rash—Dactinomycin—skin cancer	0.00107	0.00131	CcSEcCtD
Icosapent ethyl—Myalgia—Docetaxel—skin cancer	0.00106	0.0013	CcSEcCtD
Icosapent ethyl—Chest pain—Docetaxel—skin cancer	0.00106	0.0013	CcSEcCtD
Icosapent ethyl—Arthralgia—Docetaxel—skin cancer	0.00106	0.0013	CcSEcCtD
Icosapent ethyl—Dry mouth—Docetaxel—skin cancer	0.00104	0.00127	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Docetaxel—skin cancer	0.00102	0.00125	CcSEcCtD
Icosapent ethyl—Oedema—Docetaxel—skin cancer	0.00102	0.00125	CcSEcCtD
Icosapent ethyl—Dizziness—Temozolomide—skin cancer	0.00101	0.00124	CcSEcCtD
Icosapent ethyl—Infection—Docetaxel—skin cancer	0.00101	0.00124	CcSEcCtD
Icosapent ethyl—Shock—Docetaxel—skin cancer	0.001	0.00123	CcSEcCtD
Icosapent ethyl—Pruritus—Fluorouracil—skin cancer	0.000999	0.00122	CcSEcCtD
Icosapent ethyl—Tachycardia—Docetaxel—skin cancer	0.000994	0.00122	CcSEcCtD
Icosapent ethyl—Vomiting—Temozolomide—skin cancer	0.000974	0.00119	CcSEcCtD
Icosapent ethyl—Anorexia—Docetaxel—skin cancer	0.000971	0.00119	CcSEcCtD
Icosapent ethyl—Rash—Temozolomide—skin cancer	0.000966	0.00118	CcSEcCtD
Icosapent ethyl—Dermatitis—Temozolomide—skin cancer	0.000965	0.00118	CcSEcCtD
Icosapent ethyl—Dizziness—Fluorouracil—skin cancer	0.000933	0.00114	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000928	0.00114	CcSEcCtD
Icosapent ethyl—Insomnia—Docetaxel—skin cancer	0.000921	0.00113	CcSEcCtD
Icosapent ethyl—Dyspnoea—Docetaxel—skin cancer	0.000908	0.00111	CcSEcCtD
Icosapent ethyl—Vomiting—Fluorouracil—skin cancer	0.000897	0.0011	CcSEcCtD
Icosapent ethyl—Dyspepsia—Docetaxel—skin cancer	0.000897	0.0011	CcSEcCtD
Icosapent ethyl—Rash—Fluorouracil—skin cancer	0.00089	0.00109	CcSEcCtD
Icosapent ethyl—Dermatitis—Fluorouracil—skin cancer	0.000889	0.00109	CcSEcCtD
Icosapent ethyl—Decreased appetite—Docetaxel—skin cancer	0.000886	0.00109	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Docetaxel—skin cancer	0.000879	0.00108	CcSEcCtD
Icosapent ethyl—Pain—Docetaxel—skin cancer	0.000871	0.00107	CcSEcCtD
Icosapent ethyl—Constipation—Docetaxel—skin cancer	0.000871	0.00107	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Docetaxel—skin cancer	0.000839	0.00103	CcSEcCtD
Icosapent ethyl—Body temperature increased—Docetaxel—skin cancer	0.000805	0.000988	CcSEcCtD
Icosapent ethyl—Asthenia—Docetaxel—skin cancer	0.000731	0.000896	CcSEcCtD
Icosapent ethyl—Pruritus—Docetaxel—skin cancer	0.000721	0.000884	CcSEcCtD
Icosapent ethyl—Dizziness—Docetaxel—skin cancer	0.000674	0.000826	CcSEcCtD
Icosapent ethyl—Vomiting—Docetaxel—skin cancer	0.000648	0.000794	CcSEcCtD
Icosapent ethyl—Rash—Docetaxel—skin cancer	0.000642	0.000788	CcSEcCtD
Icosapent ethyl—Dermatitis—Docetaxel—skin cancer	0.000642	0.000787	CcSEcCtD
